CRON vs PAHC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

CRON

33.3
AI Score
VS
PAHC Wins

PAHC

49.9
AI Score

Investment Advisor Scores

CRON

33score
Recommendation
SELL

PAHC

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CRON PAHC Winner
Forward P/E 19.7628 13.8313 PAHC
PEG Ratio 0 1.6791 Tie
Revenue Growth 58.4% 10.3% CRON
Earnings Growth 126.8% 15.7% CRON
Tradestie Score 33.3/100 49.9/100 PAHC
Profit Margin 39.1% 6.3% CRON
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD PAHC

Relative Price Performance (Last 90 Days)

CRON 1M: +20.8% · 3M: +21.2% PAHC 1M: +6.7% · 3M: +8.5%

Current Technical Phase

CRON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.3% over 20 days), RSI 69

RSI (14): 69.3 · Price: $3.31

PAHC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.2% over 20 days), RSI 62

RSI (14): 61.7 · Price: $36.32

Fundamentals Snapshot

Metric CRON PAHC
Market Cap
Forward P/E 20.9 10.5
Trailing P/E 16.9 14.9
Revenue (TTM)
Revenue Growth 0.6% 0.1%
Gross Margin 0.4% 0.3%
Operating Margin 0.2% 0.1%
EPS 0.19 2.38
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, PAHC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.